2,504 results on '"Pantel, Klaus"'
Search Results
2. Master corepressor inactivation through multivalent SLiM-induced polymerization mediated by the oncogene suppressor RAI2
3. Diagnostic leukapheresis reveals distinct phenotypes of NSCLC circulating tumor cells
4. HERC5 downregulation in non-small cell lung cancer is associated with altered energy metabolism and metastasis
5. Relationship of Ki-67 index in biopsies of metastatic breast cancer tissue and circulating tumor cells (CTCs) at the time of biopsy collection
6. Functional characterization of PI3K C2 domain mutations detected in breast cancer circulating tumor cells and metastatic cells
7. Circulating tumour cells for early detection of clinically relevant cancer
8. A phase I prospective, non-randomized trial of autologous dendritic cell-based cryoimmunotherapy in patients with metastatic castration-resistant prostate cancer
9. Circulating tumor cells as liquid biopsy markers in cancer patients
10. EpCAM-positive circulating tumor cells and serum AFP levels predict outcome after curative resection of hepatocellular carcinoma
11. Label Efficient Classification in Liquid Biopsy Data by Self-supervision
12. Comparative analysis of EpCAM high-expressing and low-expressing circulating tumour cells with regard to their clonal relationship and clinical value
13. „Liquid biopsy“ – schon reif für Therapieentscheidungen?
14. Experimental in vitro, ex vivo and in vivo models in prostate cancer research
15. Liquid biopsy for monitoring of tumor dormancy and early detection of disease recurrence in solid tumors
16. RNF40 epigenetically modulates glycolysis to support the aggressiveness of basal-like breast cancer
17. Association Between Obesity and Circulating Tumor Cells in Early Breast Cancer Patients
18. Clinical applications and utility of cell-free DNA-based liquid biopsy analyses in cervical cancer and its precursor lesions
19. Efficacy of zoledronic acid for the elimination of disseminated tumor cells in a clinically relevant, spontaneously metastatic prostate cancer xenograft model
20. Preclinical models to study patient-derived circulating tumor cells and metastasis
21. Functional analysis of circulating tumour cells: the KEY to understand the biology of the metastatic cascade
22. The SURVIVE study: Liquid biopsy guided surveillance after intermediate- to high-risk early breast cancer.
23. Elevated levels of Protein S in Multiple Myeloma bone marrow microenvironment regulate tumor progression and bone disease
24. High Serum Levels of CCL20 Are Associated with Recurrence and Unfavorable Overall Survival in Advanced Melanoma Patients Receiving Immunotherapy
25. TAM receptors control actomyosin dynamics in osteoclasts via RHOA-COFILIN-MYOSIN II signaling
26. NSCLC patients with oligo-metastatic brain disease show an altered CD4 T-cells immune profile
27. Circulating tumor cell-blood cell crosstalk: Biology and clinical relevance
28. Heparan sulfate dependent binding of plasmatic von Willebrand factor to blood circulating melanoma cells attenuates metastasis
29. Molecular mechanisms of cancer metastasis via the lymphatic versus the blood vessels
30. Aggressive variants of prostate cancer: underlying mechanisms of neuroendocrine transdifferentiation
31. Tumorigenic circulating tumor cells from xenograft mouse models of non-metastatic NSCLC patients reveal distinct single cell heterogeneity and drug responses
32. Characterization of immunologically detectable T-cell sensitization, Immunohistochemical detection of pro-inflammatory cytokines, and clinical parameters of patients after allogeneic intraoral bone grafting procedures: a prospective randomized controlled clinical trial in humans
33. Regulation of bone homeostasis by MERTK and TYRO3
34. Emerging precision diagnostics in advanced cutaneous squamous cell carcinoma
35. C‐reactive protein flare predicts response to checkpoint inhibitor treatment in melanoma.
36. Dynamic MicroRNA-Expression In Plasma of Melanoma Patients Correlates With Progression, PD-L1 Status and Overall Survival
37. Retinoic Acid-Induced 2 Contributes to Proficient Homologous Recombination and Maintains Genomic Stability in Breast Cancer
38. Circulating Tumor Cells: From Basic to Translational Research
39. Cancer: Biology and Diagnostics
40. Frequency and Prognostic Value of Circulating Tumor Cells in Cancer of Unknown Primary
41. Detection of Multiple HPV Types in Liquid Biopsies of Cervical Neoplasia
42. Pathophysiology of Tumor Cell Release into the Circulation and Characterization of CTC
43. Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysis
44. Rationale and Design of the Hamburg City Health Study
45. Novel approaches to target the microenvironment of bone metastasis
46. Enumeration and Changes in Circulating Tumor Cells and Their Prognostic Value in Patients Undergoing Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer—Translational Research Results from the Prospective ProMPT trial
47. International liquid biopsy standardization alliance white paper
48. Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions
49. Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond
50. EGFR and PI3K Signalling Pathways as Promising Targets on Circulating Tumour Cells from Patients with Metastatic Gastric Adenocarcinoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.